Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO7795074 safety and pitavastatin pharmacokinetics study in overweight or obese healthy adults
NL-OMON60658Phase 1Completed
- Sponsor
- Genentech
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, single-arm trial of CT-996 in diabetes mellitus type 1 (T1D), sponsored by Genentech. Primary endpoint: Primary endpoint(s). Started Dec 2025; status: completed.
02
Drugs
CT-996
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on NL-OMON60658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60658.